Director, Translational Medicine Expert (Neurodegeneration)
Core
Lead end-to-end translational strategy for neurodegenerative programs, bridging preclinical research to early clinical development (Phase 1–2) and ensuring competitive differentiation of neuromuscular assets.
Role type
Director, Translational Medicine (Neurodegeneration)
Builds
Early clinical development programs (Phase 1/2) for neurodegenerative and neuromuscular assets
Domain
Biopharma / Neurodegeneration / Translational Medicine
Required skills
Translational medicine strategy, Early clinical development (Phase 1/2), Biomarker strategy, Clinical endpoint selection, Trial design, Cross-functional leadership, External scientific collaboration, Patient-centered development
Preferred skills
Pharmaceutical/biotech industry experience, PhD or MD in Neurology/Neuroscience/Neurodegenerative diseases
Technologies
Imaging platforms, Omics platforms, Data collection systems
Responsibilities
Define and execute integrated translational strategies across neurodegeneration programs; Collaborate on development and validation of molecular biomarkers and functional endpoints; Co-lead design and execution of early clinical studies; Partner with Clinical Development, Biomarker Development, and Regulatory teams; Build collaborations with academic KOLs and patient advocacy groups; Integrate patient voice into translational strategies.
Seniority
Director, Strategic Leadership & Program Management